Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2002
11/20/2002CN1380092A Zhiyusan powder for curing hemorrhoid
11/20/2002CN1380088A Medicine composition for curing coronary heart disease
11/20/2002CN1380059A Application of petroselinum sativum extract B in preparation of medicine for preventing and curing ischemic cerebral apoplexy
11/20/2002CN1094490C Quinolein-2(1H)-one derivativs as serotonin antagonists
11/20/2002CN1094369C Chinese medicinal herbs extractive and its application
11/20/2002CN1094326C Carotenoid preparation having mixture of beta-carotene, ycopene and xanthophyll
11/20/2002CA2409865A1 Hypotensive and hypertensive activities from the renal medulla
11/19/2002US6482990 Prostaglandin E analogues
11/19/2002US6482986 Benzene derivatives, preparation method and pharmaceutical compositions containing same
11/19/2002US6482956 Endothelin receptor antagonists
11/19/2002US6482948 Thienopyrimidine compounds and salts thereof and process for the preparation of the same
11/19/2002US6482852 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
11/19/2002US6482848 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/19/2002US6482841 Pyridyl compounds and pharmaceutical compositions containing them
11/19/2002US6482834 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
11/19/2002US6482832 Heterocyclically substituted amides, their production and their use
11/19/2002US6482830 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
11/19/2002US6482829 Central nervous system disorders; heeadaches, antiinflammatory agents
11/19/2002US6482825 Growth-hormone secretagogues
11/19/2002US6482822 N-(iminomethyl)amines derivatives, their preparation, their use as medicines and compositions containing them
11/19/2002US6482820 Benzazepine-n-acetic acid derivatives which contain an oxo-group in the alpha- position to the nitrogen atom and are substituted in position 3 by a 1-(carboxyalkyl)cyclo-entylcarbonylamino radical
11/19/2002US6482819 2,3-benzodiazepine derivatives
11/19/2002US6482812 Method of locking 1α-OH of vitamin D compounds in axial orientation
11/19/2002US6482811 Bretylium compositions and kits, and their use in preventing and treating cardio-vascular conditions
11/19/2002US6482800 Methods to stimulate angiogenesis
11/19/2002US6482624 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002US6482517 Coated particles, methods of making and using
11/19/2002US6482442 Substance mixture for topical application comprising olive oil and honey
11/19/2002US6482429 Stable powder inhalation dosage formulation
11/19/2002US6482417 Stable pharmaceutical formulation comprising torsemide modification II
11/19/2002CA2236422C Hydrolysis-optimized lipid emulsions and use thereof
11/19/2002CA2225780C New derivatives of n-benzylpiperazine, their preparation process and the pharmaceutical compositions they contain
11/19/2002CA2092821C Plant-based medicaments for increasing the tone and modulating the tone of the smooth muscular organs
11/19/2002CA2061706C Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
11/18/2002WO2001087855A1 Triazole derivatives
11/18/2002CA2381637A1 Compositions and methods for treating or preventing convulsions or seizures
11/15/2002WO2001090053A1 Diphenylmethane derivatives
11/15/2002CA2409144A1 Diphenylmethane derivatives
11/14/2002WO2002090546A1 Polypeptide serving as angiogenic marker and dna thereof
11/14/2002WO2002090530A2 Kinases and phosphatases
11/14/2002WO2002090524A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002WO2002090375A2 Liver x receptor agonists
11/14/2002WO2002090361A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/14/2002WO2002090355A1 N-aroyl cyclic amines
11/14/2002WO2002090353A1 Sulfonamides
11/14/2002WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002WO2002090349A1 N-oxide anthranylamide derivatives and their use as medicaments
11/14/2002WO2002090348A1 Sulfonamides
11/14/2002WO2002090347A1 Amide compounds
11/14/2002WO2002090337A1 Sulfonamides
11/14/2002WO2002090333A1 Novel pyridinone and related heterocyclic derivatives
11/14/2002WO2002090332A2 Novel aeylheteroalkylaminε derivatives
11/14/2002WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090326A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
11/14/2002WO2002090325A2 Benzazepinone alpha v integrin receptor antagonists
11/14/2002WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090314A1 Pyruvate derivatives
11/14/2002WO2002090304A1 Stable solution of reduced coenzyme q
11/14/2002WO2002090025A1 Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod and its application
11/14/2002WO2002089918A1 Utilization of rutins and aescins in the treatment of circulatory disturbances of the ear
11/14/2002WO2002089858A1 Azo compounds for type i phototherapy
11/14/2002WO2002089828A2 Interferons in the treatment of ischemia
11/14/2002WO2002089809A1 Medicinal uses of hydrazones and hydrazines
11/14/2002WO2002089807A1 Timing and duration of administration of adenosine a1/a2 agonist for cardioprotection
11/14/2002WO2002089806A1 Heterobicycles fkbp-ligands
11/14/2002WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002WO2002089799A2 Use of dihydropyrazoles to increase erythropoietin and vasculari zation
11/14/2002WO2002089793A1 Sulfonamides
11/14/2002WO2002089792A1 Sulfonamides
11/14/2002WO2002089787A1 Potentiation of therapeutic effects of fatty acids
11/14/2002WO2002089785A1 Sulfonamides
11/14/2002WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002WO2002089781A2 Methods of treating hyperlipidemia
11/14/2002WO2002089749A2 Arylsulfonamide ethers, and methods of use thereof
11/14/2002WO2002089743A2 Use of compositions for treating rosacea
11/14/2002WO2002089740A2 Sulfonamides
11/14/2002WO2002089736A2 Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment
11/14/2002WO2002081453A8 Thiohydantoins and use thereof for treating diabetes
11/14/2002WO2002076476A3 Prodrugs of anticancer agents employing substituted aromatic acids
11/14/2002WO2002074326A3 Urocortin-iii and uses thereof
11/14/2002WO2002072577A3 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
11/14/2002WO2002068457A3 Antiangiogenic peptides derived from endostatin
11/14/2002WO2002066028A3 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/14/2002WO2002064616A3 Agonists and antagonists of sphingosine-1-phosphate receptors
11/14/2002WO2002064550A8 Glucocorticoid receptor modulators
11/14/2002WO2002062373A3 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
11/14/2002WO2002055013A3 Therapeutic chromone compounds
11/14/2002WO2002055012A3 Therapeutic heterocyclic compounds
11/14/2002WO2002053167A3 Pharmaceutical combination for the treatment of tissue damage owing to an arterial irrigation defect
11/14/2002WO2002040692A3 Specific promoter of the human vascular endothelial cadherin-2 (hve-cad-2) gene and the therapeutic uses thereof
11/14/2002WO2002018623A3 Methods and reagents for protease inhibition
11/14/2002WO2002018404A3 Nucleoside derivatives for the treatment of hepatitis c
11/14/2002WO2001097787A3 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
11/14/2002WO2001035106A3 Methods for identifying and using amyloid-inhibitory compounds
11/14/2002WO2001031036A9 Modified viral surface proteins which bind to cells of tumor vasculature
11/14/2002US20020169439 Modular infusion device and method
11/14/2002US20020169336 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
11/14/2002US20020169326 Fatty acid derivatives
11/14/2002US20020169317 Oxazinocarbazoles for the treatment of CNS diseases
11/14/2002US20020169314 Sulfonamide derivative as a matrix metalloproteinase inhibitor
1 ... 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 ... 1595